Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
108 hedge funds and large institutions have $737M invested in Myovant Sciences Ltd. in 2021 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 19 closing their positions.
48% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 27
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
18% more capital invested
Capital invested by funds: $624M → $737M (+$113M)
4% more funds holding
Funds holding: 104 → 108 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
73% less call options, than puts
Call options by funds: $8.77M | Put options by funds: $32.8M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$44.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$18.2M |
| 3 |
Schroder Investment Management Group
London,
United Kingdom
|
+$5.19M |
| 4 |
Renaissance Technologies
New York
|
+$4.78M |
| 5 |
Millennium Management
New York
|
+$4.62M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$27.6M |
| 2 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$9.63M |
| 3 |
TLP
Tri Locum Partners
New York
|
-$6.61M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
-$5.35M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$5.14M |
MYOV Hedge Fund Activity: Q2 2021 in Review
108 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q2 2021, worth a combined $737M — up 18% from $624M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new MYOV positions and 19 closed out — a net gain of 4 holders — while 40 added to existing stakes and 27 trimmed.
The largest buyer was State Street, adding an estimated $44.4M. The largest seller was Lord, Abbett & Co, cutting an estimated $27.6M.
- 108 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q2 2021, up from 104 in Q1 2021.
- Funds reported $737M of Myovant Sciences Ltd. stock for Q2 2021, up 18% quarter-over-quarter.
- 23 funds opened new Myovant Sciences Ltd. positions in Q2 2021 and 19 closed out, a net change of +4 holders.
- The largest Myovant Sciences Ltd. buyer in Q2 2021 was State Street, an estimated $44.4M added.
- The largest Myovant Sciences Ltd. seller in Q2 2021 was Lord, Abbett & Co, an estimated $27.6M sold.
Based on aggregated 13F filings for Q2 2021.